Research Article

THE CONTRIBUTION OF INTESTINAL PROTOZOA TO DIARRHOEA IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY AT NATIONAL HOSPITAL ABUJA

Ayuba Hannatu U1*, Festus Igbinoba2, Philip Nwajiobi-Princewill3, Sunday A. Adewuyi4, Abbas A Abdus-Salam5, Rasaaq A. Oyesegun2, Simeon C. Aruah2, Samuel Sonibare6, Khadijah Abdulraheem6, Tobechi Akujiobi6, Aminu U1, Omonyeme Oboh3, Abdulhamid Shehu2, Dalhat Umar2, Amina I Dansani7, Philip Ayom2, Kenneth Enwerem8, Nura Shuaib2, Fatima Inno Uba9
1 Radiotherapy and Oncology Department, National Hospital Abuja, Nigeria
2 Radiotherapy and Oncology Department, National Hospital Abuja, Nigeria.
3 Medical Microbiology Department, National Hospital Abuja, Nigeria.
4 Department of Radiation and Clinical Oncology, Ahmadu Bello University Teaching Hospital Zaria, Nigeria.
5 Radiation Oncology Department, University College Hospital, Ibadan, Oyo State, Nigeria
6 Medical Microbiology Department, National Hospital Abuja, Nigeria
7 Department of Radiation and Clinical Oncology, Federal Teaching Hospital Katsina, Katsina State, Nigeria
8 Institute of Human Virology, Abuja, Nigeria.
9 Department of Radiotherapy, National Hospital, Abuja, Nigeria
* Corresponding author: hannatuayuba@gmail.com
Published: Jul, 2025
DOI: 10.67579/njo.2025.mgmk2wzb
Pages: 201-207
Views: 270
Downloads: 174

Abstract

Background: Diarrhoea is one of the most critical health problems worldwide. In addition, vital symptom burden in cancer patients undergoing chemotherapy, which can worsen the disease condition with poor outcomes in the presence of intestinal protozoa infestations. The study assessed the contribution of intestinal protozoa to diarrhoea in breast cancer patients undergoing chemotherapy at National Hospital Abuja. The increasing cancer burden in low and middle-income countries LMICs with emerging intestinal protozoa of public health significance makes it essential to screen such high-risk populations.

Methods: This study was an observational, case-control study of breast cancer patients undergoing chemotherapy at the Radiotherapy and Oncology Department of the National Hospital Abuja. Stool samples of breast cancer patients undergoing chemotherapy were analysed. Clinical and demographic data, along with laboratory results of the stool assays of the cases and control groups, were explored.

Results: Prevalence of intestinal protozoa in patients with diarrhoea was 24(47.1%). Twenty (39.2%) of the patients diagnosed with intestinal protozoa had complicated diarrhoea as compared with 18 (35.2%) without intestinal protozoa with complicated diarrhoea.

Conclusion: Cryptosporidium, Entaemoeba coli and Entamoeba histolytica were isolated and found to also contribute to diarrhoea in our breast cancer patients on chemotherapy.

Keywords

Diarrhoea Complicated diarrhoea Infective diarrhoea Intestinal protozoa Chemotherapy Entamoeba spp. Blastocystis spp. Cryptosporidiosis Giardiasis

References

  1. M.M Sanad; F. A Thagfan, A. Al Hammad, E.M Olayan, A. Almogren. Opportunistic Coccidian Parasites among Saudi Cancer Patients Presenting with Diarrhea: Prevalence and Immune Status [Internet]. Cited: [https://scialert.net/fulltext/?doi=jp.2014.55.63](https://scialert.net/fulltext/?doi=jp.2014.55.63)
  2. Stein A, Voigt W, Jordan K. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol. 2010; 2(1):51. Cited: /pmc/articles/PMC3126005/
  3. Sitotaw E, Sitotaw A, Aleka Y, Lemma M. Prevalence of Intestinal Helminths among Cancer Patients Who Are under Chemotherapy at the University of Gondar Comprehensive Specialized Hospital Oncology Clinic, Northwest Ethiopia. J Cancer Epidemiol. 2022:4484183.
  4. Al-Qobati SA, Al-Maktari MT, Al-Zoa AMB, Derhim M. Intestinal parasitosis among Yemeni patients with cancer, Sana’a, Yemen. J Egypt Soc Parasitol. 2012; 42(3):727–34. Cited: [https://pubmed.ncbi.nlm.nih.gov/23469646/](https://pubmed.ncbi.nlm.nih.gov/23469646/)
  5. Al-Yousofi A, Aabarhara Y. “Prevalence of Intestinal Parasites among Immunocompromised Patients, Children, and Adults in Sana’a, Yemen”,0. J Trop Med. 2022;42(3):727-734.
  6. Banihashemi SM, Soleymani E, Abdizadeh R, Motavalli Haghi M, Khalili B. Intestinal Protozoan Infections in Cancer Patients Undergoing Chemotherapy in Shahrekord the Central Southwest of Iran in 2018. Int J Epidemiol Res. 2020 Nov 1; 7(4):144–51. Cited: [http://ijer.skums.ac.ir/article_44726.html](https://www.google.com/search?q=http://ijer.skums.ac.ir/article_44726.html)
  7. Łanocha A, Łanocha-Arendarczyk N, Wilczyńska D, Zdziarska B, & Kosik-Bogacka D. Protozoan Intestinal Parasitic Infection in Patients with Hematological Malignancies. J Clin Med. 2022; 11(10). Cited: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146298/](https://www.google.com/search?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146298/)
  8. Izadi S, Ghayour-Najafabadi Z, Yavari M, Mohaghegh MA, Wannigama DL, Moslemzadeh HR, et al. Intestinal Parasites Associated with Opportunistic Coccidial Infections Among Immunocompromised Individuals in Central Iran: A Cross-Sectional Study. Arch Clin Infect Dis 2019 142. 2019; 14(2):79701. Cited: [https://brieflands.com/articles/archcid-79701.html](https://www.google.com/search?q=https://brieflands.com/articles/archcid-79701.html)
  9. El-Nemr; AAAMWAEGHI, A. EHA. Prevalence of Intestinal Parasites in Cancer Therapy Recipients with Concurrent Diarrhea. Int J Trop Dis Heal. 2016; 15(1):1–7. Cited: www.sciencedomain.org
  10. J Guarner, R Villasenor-Flores, G Sanchez-Memoranda, T Mailed-Nava. Frequency of intestinal parasites in adult cancer patients in Mexico. Arch Med Res. 1997;28(2):219-222
  11. Taşova Y, Şahin B, Koltaş S, Paydaş S. Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med Okayama. 2000; 54(3):133–6. Cited: [https://pubmed.ncbi.nlm.nih.gov/10925738/](https://pubmed.ncbi.nlm.nih.gov/10925738/)
  12. El-Badry AA, El Sayed SS, Hussein RR, Said YM, Al-Antably AS, Hassan MA. Intestinal parasitism in pediatric oncology children receiving chemotherapy: unexpected low prevalence. Heliyon. 2019;5(8):e02228.
  13. Schmidt-Hieber M, Bierwirth J, Buchheidt D, Cornely OA, Hentrich M, Maschmeyer G, et al. Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol. 2017; 97(1):31–49. Cited: [https://link.springer.com/article/10.1007/s00277-017-3183-7](https://link.springer.com/article/10.1007/s00277-017-3183-7)
  14. Radojevic MZ, Tomasevic A, Karapandzic VP, Milosavljevic N, Jankovic S, Folic M. Acute chemoradiotherapy toxicity in cervical cancer patients. Open Med. 2020; 15(1):822–32.
How to Cite

U, A. H., Igbinoba, F., Nwajiobi-Princewill, P., Adewuyi, S. A., Abdus-Salam, A. A., Oyesegun, R. A., Aruah, S. C., Sonibare, S., Abdulraheem, K., Akujiobi, T., U, A., Oboh, O., Shehu, A., Umar, D., Dansani, A. I., Ayom, P., Enwerem, K., Shuaib, N., & Uba, F. I. (2025). THE CONTRIBUTION OF INTESTINAL PROTOZOA TO DIARRHOEA IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY AT NATIONAL HOSPITAL ABUJA. Nigerian Journal of Oncology, 1(2), 201-207. https://doi.org/10.67579/njo.2025.mgmk2wzb

A. H. U, F. Igbinoba, P. Nwajiobi-Princewill, S. A. Adewuyi, A. A. Abdus-Salam, R. A. Oyesegun, S. C. Aruah, S. Sonibare, K. Abdulraheem, T. Akujiobi, A. U, O. Oboh, A. Shehu, D. Umar, A. I. Dansani, P. Ayom, K. Enwerem, N. Shuaib, and F. I. Uba, "THE CONTRIBUTION OF INTESTINAL PROTOZOA TO DIARRHOEA IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY AT NATIONAL HOSPITAL ABUJA," Nigerian Journal of Oncology, vol. 1, no. 2, pp. 201-207, July 2025. doi: 10.67579/njo.2025.mgmk2wzb

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles